You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

AZELASTINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Azelastine Hydrochloride, and when can generic versions of Azelastine Hydrochloride launch?

Azelastine Hydrochloride is a drug marketed by Alembic, Apotex Inc, Epic Pharma Llc, Gland Pharma Ltd, Sandoz, Somerset Theraps Llc, Sun Pharm, Alkem Labs Ltd, Amneal, Aurobindo Pharma Ltd, Bionpharma, Hikma, Padagis Israel, Sciegen Pharms Inc, Upsher Smith Labs, Zydus Pharms, and Apotex. and is included in twenty-eight NDAs.

The generic ingredient in AZELASTINE HYDROCHLORIDE is azelastine hydrochloride; fluticasone propionate. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride; fluticasone propionate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AZELASTINE HYDROCHLORIDE?
  • What are the global sales for AZELASTINE HYDROCHLORIDE?
  • What is Average Wholesale Price for AZELASTINE HYDROCHLORIDE?
Drug patent expirations by year for AZELASTINE HYDROCHLORIDE
Recent Clinical Trials for AZELASTINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MEDA Pharma GmbH & Co. KGPhase 2
SandozPhase 1
Nanjing University of Chinese MedicineN/A

See all AZELASTINE HYDROCHLORIDE clinical trials

Pharmacology for AZELASTINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for AZELASTINE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CHILDREN'S ASTEPRO ALLERGY Nasal Spray azelastine hydrochloride 205.5 mcg/spray 213872 1 2021-07-12
ASTEPRO Nasal Spray azelastine hydrochloride 205.5 mcg/spray 022203 2011-12-15
OPTIVAR Ophthalmic Solution azelastine hydrochloride 0.05% 021127 1 2006-12-13
ASTELIN Nasal Spray azelastine hydrochloride 0.125 mg base/spray 020114 1 2005-11-14

US Patents and Regulatory Information for AZELASTINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Padagis Israel AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE azelastine hydrochloride; fluticasone propionate SPRAY, METERED;NASAL 208111-001 Feb 18, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex AZELASTINE HYDROCHLORIDE CHILDREN'S ALLERGY azelastine hydrochloride SPRAY, METERED;NASAL 216421-002 May 29, 2024 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic AZELASTINE HYDROCHLORIDE azelastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 209620-001 Mar 20, 2019 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma AZELASTINE HYDROCHLORIDE azelastine hydrochloride SPRAY, METERED;NASAL 091444-001 Oct 24, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Upsher Smith Labs AZELASTINE HYDROCHLORIDE azelastine hydrochloride SPRAY, METERED;NASAL 202609-001 Mar 17, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm AZELASTINE HYDROCHLORIDE azelastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 078738-001 Jun 21, 2010 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd AZELASTINE HYDROCHLORIDE azelastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 210092-001 Feb 25, 2020 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.